Nan Fung Group appeared to be the Corporate Investor, which was created in 1954. The company was established in Asia in Hong Kong. The main office of represented Corporate Investor is situated in the Central.
Moreover, a startup needs to be at the age of 2-3 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Fog Pharmaceuticals. We can highlight the next thriving fund investment areas, such as Biotechnology, Health Care. For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States.
The standard case for the fund is to invest in rounds with 5-6 partakers. Despite the Nan Fung Group, startups are often financed by ZWC Partners. The meaningful sponsors for the fund in investment in the same round are WuXi AppTec, Tiantu Capital, Leerink Partners.
The fund is constantly included in less than 2 deals per year. The common things for fund are deals in the range of 50 - 100 millions dollars. The important activity for fund was in 2018.
Related Funds
| Fund Name | Location |
| Alturki Holding | Al Khobar, Ash Sharqiyah, Saudi Arabia |
| Aphria | Canada, Leamington, Ontario |
| Cocoon Wealth | England, London, United Kingdom |
| Highway1 | California, San Francisco, United States |
| Jack Henry & Associates | Missouri, Monett, United States |
| Kerala Startup Mission | India, Kerala, Trivandrum |
| Payfort | Dubai, United Arab Emirates |
| Quantum Strategic Partners | New York, New York, United States |
| Saints Capital | California, San Francisco, United States |
| Springboard Capital | Florida, Jacksonville, United States |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
| $60M | 21 Jan 2021 | Shanghai | |||
Fog Pharmaceuticals | $66M | 16 May 2018 | Cambridge, Massachusetts, United States | ||
Baletu | 10 May 2018 | Shanghai, China | |||
Surkus | 01 Jan 2017 | West Hollywood, California, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
| $60M | 21 Jan 2021 | Shanghai | |||
Fog Pharmaceuticals | $66M | 16 May 2018 | Cambridge, Massachusetts, United States | ||
Baletu | 10 May 2018 | Shanghai, China | |||
Surkus | 01 Jan 2017 | West Hollywood, California, United States |
